title: [Calcium-phosphorus metabolic disorders and the primary care (discussion)].
authors.forename: Yoshiki
authors.initials: Y
authors.lastname: Seino
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Takeuchi
authors.forename: Atsushi
authors.initials: A
authors.lastname: Suzuki
authors.forename: Takeshi
authors.initials: T
authors.lastname: Kondo
authors.forename: Yoshitaka
authors.initials: Y
authors.lastname: Yamanaka
mesh_terms: D003937:Diagnosis, Differential; D000089703:Fibroblast Growth Factor-23; D005346:Fibroblast Growth Factors / Q000235:genetics / Q000502:physiology; D006801:Humans; D006934:Hypercalcemia / Q000175:diagnosis* / Q000209:etiology / Q000503:physiopathology; D006996:Hypocalcemia / Q000175:diagnosis* / Q000209:etiology / Q000503:physiopathology; D017674:Hypophosphatemia / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D009154:Mutation; D053402:PHEX Phosphate Regulating Neutral Endopeptidase / Q000235:genetics / Q000502:physiology; D012279:Rickets / Q000175:diagnosis* / Q000209:etiology*
chemical_list: D005346:Fibroblast Growth Factors; D000089703:Fibroblast Growth Factor-23; D053402:PHEX Phosphate Regulating Neutral Endopeptidase